743.76 - 757.57
479.80 - 796.25
8.25M / 11.73M (Avg.)
27.40 | 27.58
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-3.21%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-2.58%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-5.78%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-5.78%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
22.88%
Positive net income growth while BIDU is negative. John Neff might see a big relative performance advantage.
19.05%
Positive EPS growth while BIDU is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
25.00%
Positive diluted EPS growth while BIDU is negative. John Neff might view this as a strong relative advantage in controlling dilution.
2.10%
Share count expansion well above BIDU's 0.06%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
1.99%
Diluted share count expanding well above BIDU's 0.07%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
4.39%
OCF growth of 4.39% while BIDU is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
23.26%
FCF growth of 23.26% while BIDU is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
223.71%
10Y revenue/share CAGR under 50% of BIDU's 10085.36%. Michael Burry would suspect a lasting competitive disadvantage.
223.71%
5Y revenue/share CAGR under 50% of BIDU's 1054.34%. Michael Burry would suspect a significant competitive gap or product weakness.
223.71%
3Y revenue/share CAGR at 75-90% of BIDU's 287.92%. Bill Ackman would expect new product strategies to close the gap.
252.27%
OCF/share CAGR of 252.27% while BIDU is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
252.27%
OCF/share CAGR of 252.27% while BIDU is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
252.27%
3Y OCF/share CAGR of 252.27% while BIDU is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
159.38%
Below 50% of BIDU's 26469.05%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
159.38%
Below 50% of BIDU's 1279.38%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
159.38%
3Y net income/share CAGR 1.25-1.5x BIDU's 135.66%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-9.29%
Firm’s AR is declining while BIDU shows 6.12%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
6.33%
Asset growth above 1.5x BIDU's 3.37%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
5.96%
BV/share growth above 1.5x BIDU's 3.38%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-17.65%
We’re deleveraging while BIDU stands at 2.52%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
11.52%
R&D growth drastically higher vs. BIDU's 1.01%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
-7.78%
We cut SG&A while BIDU invests at 7.83%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.